Search research articles
Contact Us
Filters
Showing results (51-60 of 75) with videos related to
Page
of 8
Sort By:
Journal of Neurology
|
September 10, 2020
A systematic review of neuropsychiatric and cognitive assessments used in clinical trials for amyotrophic lateral sclerosis
Emily Beswick, Emily Park, Charis Wong, et al.
Nature Medicine
|
September 14, 2023
The role of placebo control in clinical trials for neurodegenerative diseases
Arpan R Mehta, James R Carpenter, Jennifer M Nicholas, et al.
European Journal of Neurology
|
May 26, 2021
Prevalence of multimorbidity and its impact on survival in people with motor neuron disease
Stella A Glasmacher, Patrick K A Kearns, Juan Larraz, et al.
Brain Communications
|
March 6, 2020
Targeting mitochondrial dysfunction in amyotrophic lateral sclerosis: a systematic review and meta-analysis
Arpan R Mehta, Rachel Walters, Fergal M Waldron, et al.
Frontiers in Molecular Neuroscience
|
April 5, 2021
40 Years of CSF Toxicity Studies in ALS: What Have We Learnt About ALS Pathophysiology?
Koy Chong Ng Kee Kwong, Pratap K Harbham, Bhuvaneish T Selvaraj, et al.
Practical Neurology
|
July 12, 2024
Reframing the clinical phenotype and management of cryptococcal meningitis
Maria Francisca Rocha, Hamish D C Bain, Neil Stone, et al.
Brain : a Journal of Neurology
|
February 26, 2013
The functional neuroimaging correlates of psychogenic versus organic dystonia
Anette E Schrag, Arpan R Mehta, Kailash P Bhatia, et al.
The Lancet. Infectious Diseases
|
June 21, 2025
Tetanus: recognition and management
Raghav Sudarshan, Ana Ria Sayo, David Roman Renner, et al.
Journal of Neurology
|
September 5, 2020
The immediate impact of the COVID-19 pandemic on motor neuron disease services and mortality in Scotland
Stella A Glasmacher, Juan Larraz, Arpan R Mehta, et al.
Journal of Neurology
|
October 20, 2020
Correction to: The immediate impact of the COVID‑19 pandemic on motor neuron disease services and mortality in Scotland
Stella A Glasmacher, Juan Larraz, Arpan R Mehta, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 75) with videos related to
Sort By:
Page
of 8
Journal of Neurology
|
September 10, 2020
A systematic review of neuropsychiatric and cognitive assessments used in clinical trials for amyotrophic lateral sclerosis
Emily Beswick, Emily Park, Charis Wong, et al.
Nature Medicine
|
September 14, 2023
The role of placebo control in clinical trials for neurodegenerative diseases
Arpan R Mehta, James R Carpenter, Jennifer M Nicholas, et al.
European Journal of Neurology
|
May 26, 2021
Prevalence of multimorbidity and its impact on survival in people with motor neuron disease
Stella A Glasmacher, Patrick K A Kearns, Juan Larraz, et al.
Brain Communications
|
March 6, 2020
Targeting mitochondrial dysfunction in amyotrophic lateral sclerosis: a systematic review and meta-analysis
Arpan R Mehta, Rachel Walters, Fergal M Waldron, et al.
Frontiers in Molecular Neuroscience
|
April 5, 2021
40 Years of CSF Toxicity Studies in ALS: What Have We Learnt About ALS Pathophysiology?
Koy Chong Ng Kee Kwong, Pratap K Harbham, Bhuvaneish T Selvaraj, et al.
Practical Neurology
|
July 12, 2024
Reframing the clinical phenotype and management of cryptococcal meningitis
Maria Francisca Rocha, Hamish D C Bain, Neil Stone, et al.
Brain : a Journal of Neurology
|
February 26, 2013
The functional neuroimaging correlates of psychogenic versus organic dystonia
Anette E Schrag, Arpan R Mehta, Kailash P Bhatia, et al.
The Lancet. Infectious Diseases
|
June 21, 2025
Tetanus: recognition and management
Raghav Sudarshan, Ana Ria Sayo, David Roman Renner, et al.
Journal of Neurology
|
September 5, 2020
The immediate impact of the COVID-19 pandemic on motor neuron disease services and mortality in Scotland
Stella A Glasmacher, Juan Larraz, Arpan R Mehta, et al.
Journal of Neurology
|
October 20, 2020
Correction to: The immediate impact of the COVID‑19 pandemic on motor neuron disease services and mortality in Scotland
Stella A Glasmacher, Juan Larraz, Arpan R Mehta, et al.
Page
of 8